11/13
06:51 pm
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $65.00 price target on the stock.
Medium
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $65.00 price target on the stock.
11/13
06:29 pm
rna
Rating for RNA
Medium
Report
Rating for RNA
11/13
08:06 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
High
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
11/13
04:56 am
rna
Rating for RNA
High
Report
Rating for RNA
11/13
04:56 am
rna
Rating for RNA
High
Report
Rating for RNA
10/31
08:35 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Low
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
10/31
05:31 am
rna
Rating for RNA
Medium
Report
Rating for RNA
10/31
05:31 am
rna
Rating for RNA
Medium
Report
Rating for RNA
10/30
09:24 am
rna
Rating for RNA
Medium
Report
Rating for RNA
9/24
06:44 am
rna
Rating for RNA
Low
Report
Rating for RNA
9/24
06:44 am
rna
Rating for RNA
Low
Report
Rating for RNA
9/24
06:44 am
rna
Rating for RNA
Low
Report
Rating for RNA
9/18
09:19 am
rna
Rating for RNA
Low
Report
Rating for RNA
9/16
01:06 pm
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $96.00 price target on the stock.
Low
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $96.00 price target on the stock.
9/16
12:59 pm
rna
Rating for RNA
Low
Report
Rating for RNA
9/9
12:14 pm
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $96.00 price target on the stock.
Low
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $96.00 price target on the stock.
9/9
12:06 pm
rna
Rating for RNA
Low
Report
Rating for RNA
8/28
08:33 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $63.00 price target on the stock.
Low
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $63.00 price target on the stock.
8/28
08:27 am
rna
Rating for RNA
Low
Report
Rating for RNA
8/28
08:27 am
rna
Rating for RNA
Low
Report
Rating for RNA
8/26
09:14 am
rna
Rating for RNA
Low
Report
Rating for RNA